Matches in Nanopublications for { ?s ?p "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP468187.RA7I68zG6oGZhbRJiiaBrsYxRCK1QaD5_fJDABxHCpiV0130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468187.RA7I68zG6oGZhbRJiiaBrsYxRCK1QaD5_fJDABxHCpiV0130_provenance.
- NP660103.RAl3b5EHPhf2Nm94c075mJHHyGJZ1lkf5g7xMfq1exhXs130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660103.RAl3b5EHPhf2Nm94c075mJHHyGJZ1lkf5g7xMfq1exhXs130_provenance.
- NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305376.RA6mCu8FmG4UzXEK7S5qLt98SjuS3x_ghFAmC4n56ntyY130_provenance.
- NP334328.RAT0w645ccNqlWv6_fzwo3wJlnjKdAFFrw8fzUIYiVZAA130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334328.RAT0w645ccNqlWv6_fzwo3wJlnjKdAFFrw8fzUIYiVZAA130_provenance.
- NP897000.RAR8xsTLDUkKjpBiHNlk0fpf05xlRutzCQoBAYdfVvR5k130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897000.RAR8xsTLDUkKjpBiHNlk0fpf05xlRutzCQoBAYdfVvR5k130_provenance.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.
- NP981201.RAVesxs-r3IwWprEV6rg9Q7Wo8EZ86NoHwwvJudAzsr38130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981201.RAVesxs-r3IwWprEV6rg9Q7Wo8EZ86NoHwwvJudAzsr38130_provenance.
- NP334174.RAAX9KVVzBolkCVxkbz1KKT3Su3HuWk_imE05rKs7l19U130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334174.RAAX9KVVzBolkCVxkbz1KKT3Su3HuWk_imE05rKs7l19U130_provenance.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.
- NP896973.RAoV6cgrP9ZszUQ_8IrEoYXrZmPVJEq4bkgW_VxTF-JOw130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896973.RAoV6cgrP9ZszUQ_8IrEoYXrZmPVJEq4bkgW_VxTF-JOw130_provenance.
- NP965266.RA78Mks3Rs3w9gbmHGDMY2-VYAb-Ep3AngvKL3cn4untM130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965266.RA78Mks3Rs3w9gbmHGDMY2-VYAb-Ep3AngvKL3cn4untM130_provenance.